Influenza Virus and Epstein-Barr Virus Peptides

Home » What we do » Catalogue Peptides » Influenza virus and Epstein-Barr virus peptides

Influenza virus and Epstein-Barr virus peptides

CEF product	Peptide sequence	Catalog no.	Quantity	GBP
CEF1, Influenza Matrix Protein M1 (58 – 66)	GILGFVFTL	AB-CEF001	1 mg	£105
CEF2, Influenza Virus PA (46 – 54)	FMYSDFHFI	AB-CEF002	1 mg	£105
CEF3, Influenza Virus M1 (13 – 21)	SIIPSGPLK	AB-CEF003	1 mg	£105
CEF4, Influenza Virus NP (342 – 351)	RVLSFIKGTK	AB-CEF004	1 mg	£105
CEF5, Influenza Virus NP (91 – 99)	KTGGPIYKR	AB-CEF005	1 mg	£105
CEF6, Influenza Virus NP	LPFDKTTVM	AB-CEF006	1 mg	£105
CEF7, Influenza Virus NP (380 – 388)	ELRSRYWAI	AB-CEF007	1 mg	£105
CEF8, Influenza Virus NP (383 – 391)	SRYWAIRTR	AB-CEF008	1 mg	£105
CEF9, Influenza Virus M1 128 – 135	ASCMGLIY	AB-CEF009	1 mg	£105
CEF10, Epstein – Barr Virus LMP2 (426 – 434)	CLGGLLTMV	AB-CEF010	1 mg	£105
CEF11, Epstein – Barr Virus BMLF1 (280 – 288)	GLCTLVAML	AB-CEF011	1 mg	£105
CEF12, Epstein – Barr Virus latent NA3B (399 – 408), AVF	AVFDRKSDAK	AB-CEF012	1 mg	£105
CEF14, Epstein – Barr Virus RTA Protein (28 – 37)	DYCNVLNKEF	AB-CEF014	1 mg	£105
CEF15, Epstein – Barr Virus Lytic Cycle Protein BZLF – 1(190 – 197)	RAKFKQLL	AB-CEF015	1 mg	£105
CEF16, Epstein – Barr Virus latent NA – 3A (337 – 347)	FLRGRAYGL	AB-CEF016	1 mg	£105
CEF17, Epstein – Barr Virus latent NA – 3A (158 – 166)	QAKWRLQTL	AB-CEF017	1 mg	£105
CEF18, Epstein – Barr Virus latent NA – 3C (258 – 266)	RRIYDLIEL	AB-CEF018	1 mg	£105
CEF19, Epstein – Barr Virus latent NA – 3A (458 – 466)	YPLHEQHGM	AB-CEF019	1 mg	£105
CEF20, Cytomegalovirus, CMV pp65 (495 – 503)	NLVPMVATV	AB-CEF020	1 mg	£105
CEF21, Cytomegalovirus, CMV pp65 (417 – 426)	TPRVTGGGAM	AB-CEF021	1 mg	£105
CEF22, Cytomegalovirus, CMV pp65 (378 – 389)	SDEEEAIVAYTL	AB-CEF022	1 mg	£105
CEF23, Cytomegalovirus, CMV pp65 (123 – 131)	IPSINVHHY	AB-CEF023	1 mg	£105
CEF24, Influenza Virus PB1 Peptide (591 – 599)	VSDGGPNLY	AB-CEF024	1 mg	£105
CEF25, Influenza Virus NP (44 – 52)	CTELKLSDY	AB-CEF025	1 mg	£105
CEF26, Influenza Virus NP (265 – 274)	ILRGSVAHK	AB-CEF026	1 mg	£105
CEF27, Epstein – Barr Virus BRLF – 1 lytic (148 – 156)	RVRAYTYSK	AB-CEF027	1 mg	£105
CEF28, Epstein – Barr Virus latent NA – 3A (603 – 611)	RLRAEAQVK	AB-CEF028	1 mg	£105
CEF29, Epstein – Barr Virus latent NA – 3B (416 – 424)	IVTDFSVIK	AB-CEF029	1 mg	£105
CEF30, Epstein – Barr Virus BRLF1 (134 – 142)	ATIGTAMYK	AB-CEF030	1 mg	£105
CEF31, Epstein – Barr Virus latent NA – 3A (379 – 387)	RPPIFIRRL	AB-CEF031	1 mg	£105
CEF32, Epstein – Barr Virus latent NA – 3C (281 – 290)	EENLLDFVRF	AB-CEF032	1 mg	£105
CEF33, Cytomegalovirus, HCMV pp65	EFFWDANDIY	AB-CEF033	1 mg	£105

7 July 2026

Investigating the Role of Zika Virus Small Membrane M Protein with Synthetic Peptides

Learn how our synthetic peptides enabled groundbreaking research into Zika virus infectivity and viroporin biology at the University of Leeds.

14 May 2025

Fluorescent Peptides: A Guide for Life Science Researchers

Explore key considerations for designing fluorescent peptides, including dye selection, spacers, handling, and storage. Read our guide.

25 March 2025

Peptide Synthesis: An Overview

Peptide synthesis is a cornerstone of modern science, underpinning advances in medicine, biotechnology, and fundamental research that enable the creation of molecules that drive advancements in medicine, research, and technology.

Influenza and Epstein-Barr virus peptides